HR Execs on the Move


 
Wheel is the health tech company putting great care within everyone`s reach. We provide everything companies and clinicians need to serve patients virtually, including a complete virtual care platform and nationwide clinician network. Our offering makes it easy for companies to build virtual care services and for clinicians to manage their practice in one place — including onboarding, support, and the ability to work across several highly-vetted opportunities. Imagine a future without waiting rooms, where patients are quickly seen by the best clinician for their care need, who is happily working on their own schedule and on their own terms. ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.wheel.com
  • 2330 South Lamar Boulevard Suite 300
    Austin, TX USA 78701
  • Phone: 512.850.5498

Executives

Name Title Contact Details
Vincent Balsamo
Chief Revenue Officer Profile
Brandon Castel
Vice President of Sales Profile
Shoshana Deutschkron
Chief Marketing Officer Profile
Alex Priest
Chief of Staff Profile

Similar Companies

Eye Surgeon Associates

Eye Surgeon Associates is a Bettendorf, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Welch Healthcare and Retirement

Welch Healthcare & Retirement is a Norwell, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cvi Medical Liquidators-Tx

Cvi Medical Liquidators-Tx is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kryptiq Corporation

Kryptiq is the leading provider of interoperability and workflow connectivity solutions for healthcare.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.